Le Lézard
Classified in: Science and technology, Business
Subject: BOARD OF DIRECTORS

Changes to the Board of Directors of Transcontinental Inc.: departure of Mr. André Tremblay and appointment of Mr. Yves Leduc


MONTREAL, QUEBEC--(Marketwired - Sept. 7, 2017) - Transcontinental Inc. (TSX:TCL.A)(TSX:TCL.B) announces the departure of Mr. André Tremblay and the appointment of Mr. Yves Leduc to the Corporation's Board of Directors. Mr. Tremblay, Managing Partner at Trio Capital Inc., has served on the Board of Transcontinental Inc. for the last 10 years. He significantly contributed to the Corporation's success and proved to be a strong ally during its strategic transformation. The Board of Directors welcomes Mr. Leduc, President and Chief Executive Officer of Velan Inc., one of the world's leading manufacturers of industrial valves. A renowned leader, he has close to 30 years of vast experience both in Canada and internationally, in the areas of manufacturing operations, product development, sales and marketing.

"During his tenure, Mr. André Tremblay played a prominent role on the Board of Directors," said Ms. Isabelle Marcoux, Chair of the Board of Transcontinental Inc. His judgment, integrity, vast experience and creative spirit have benefited us and I sincerely thank him for his sound guidance. As Chair of the Human Resources and Compensation Committee, he significantly contributed to our ongoing transformation into packaging and, for that, we are most grateful to him. On behalf of all the directors, I wish him much continued success. 

"Furthermore, it is with enthusiasm that I welcome Mr. Yves Leduc to the Board of Directors of Transcontinental Inc.", continued Ms. Marcoux. I am confident that the Corporation will benefit from his long-standing manufacturing expertise, his strong product development experience as well as his involvement in the development of numerous innovation processes. Together with all members of the Board, we will pursue our work toward the Corporation's lasting growth for the benefit of our shareholders."

Mr. Yves Leduc joined Velan Inc. as President in January 2015 and also became its Chief Executive Officer in 2017. Previously employed at BRP for 16 years, he held various senior management positions, including Vice President General Manager of the North America division as of 2006. During his previous mandates, Mr. Leduc worked at McKinsey & Company as a management consultant where he carried out projects in North America and Europe, and as a lawyer with Stikeman Elliott in Montreal. A man of active involvement, particularly in the areas of education and culture, he currently serves on the board of Orford Music and, until recently, on the boards of Corporation études-sports (Studies and Sports Corporation) of the Université de Sherbrooke and the Accelerator for the creation of technological businesses group of the Université de Sherbrooke. A lawyer by training, he is a graduate of the Université de Montréal and of Columbia University in New York.

About TC Transcontinental

Canada's largest printer with operations in print, flexible packaging, publishing and digital media, TC Transcontinental's mission is to create products and services that allow businesses to attract, reach and retain their target customers.

Respect, teamwork, performance and innovation are strong values held by the Corporation and its employees. The Corporation's commitment to its stakeholders is to pursue its business and philanthropic activities in a responsible manner.

Transcontinental Inc. (TSX:TCL.A)(TSX:TCL.B), known as TC Transcontinental, has more than 7,000 employees in Canada and the United States, and revenues of C$2.0 billion in 2016. Website www.tc.tc


These press releases may also interest you

at 22:03
The report titled "Anti-Mullerian Hormone Test Market by Product (POC Testing, Self-check Kits), End-User (Commercial Labs, Research & development), Distribution, Use - Global Forecast 2024-2030" is now available on 360iResearch.com's offering,...

at 20:40
Rakovina Therapeutics Inc. a biopharmaceutical company committed to advancing new cancer therapies based on novel DNA-damage response technologies announced the financial results for its fourth quarter and fiscal year ending December 31, 2023 and...

at 20:15
The partnership was unveiled internally at the Franchisor's annual convention in Las Vegas, NV in December 2023, eliciting...

at 19:40
ReNAgade Therapeutics, a company unlocking the limitless potential for RNA medicines, today announced its ongoing commitment to exploring the therapeutic opportunity of glycobiology through support for ongoing research at GanNA Bio, and the...

at 18:57
Tribe Property Technologies Inc. (the "Issuer" or the "Company") , a leading provider of technology-elevated property management solutions, today announced that it expects to complete and file its 2023 Annual Filings (as defined below) on or before...

at 18:47
The Korean Cultural Center New York (KCCNY), a branch of the Ministry of Culture, Sports and Tourism of the Republic of Korea, is proud to present a special exhibition "Whanki in New York," from May 2 to June 13, 2024. This exhibition commemorates...



News published on and distributed by: